P449: NOVEL, FIRST-IN-CLASS, SOMATIC IDH2 DELETION-INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN-VITRO (Q113817349)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | P449: NOVEL, FIRST-IN-CLASS, SOMATIC IDH2 DELETION-INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN-VITRO |
scientific article published in 2022 |
Statements
P449: NOVEL, FIRST-IN-CLASS, SOMATIC IDH2 DELETION-INSERTION VARIANT C.516_518DELINSTGC CONFERS BORDERLINE PHENOTYPE AND DOES NOT SHOW SUSCEPTIBILITY TO ENASIDENIB IN-VITRO (English)
L. Ruhnke
D. M. Poitz
S. Herold
S. Dressler
C. Dill
M. Peitzsch
U. Oelschlägel
J. Frimmel
D. Kunadt
T. Kretschmann
H. Altmann
F. Stölzel
C. Röllig
T. Chavakis
G. Baretton
K. Schäfer-Eckart
M. Bornhäuser
June 2022
349-350